Literature DB >> 16386855

The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role?

A Ismail1, E A G Khalil, A M Musa, I M El Hassan, M E Ibrahim, T G Theander, A M El Hassan.   

Abstract

Post kala-azar dermal leishmaniasis (PKDL) is a dermatosis caused by persistence of Leishmania donovani parasites in the skin following apparently successful treatment of visceral leishmaniasis. The distribution of PKDL lesions in Sudanese patients often mirrors the clothing habits of those affected. It is most severe in or confined to the sun-exposed parts of the skin. It is well established that elimination of Leishmania parasites requires activation of parasitised macrophages by a Th1 immune response and that the latter is depressed by ultraviolet light (UVB). In this paper, we hypothesized that UVB light might be a key player in the pathogenesis of PKDL. This paper links observations made in the field with immunological data that are compatible with this hypothesis. We therefore investigated patients with PKDL immunologically for a possible role of UVB exposure in the pathogenesis of this condition. We marshal evidence that the changes in the tissues are compatible with the effects of UVB light and it is probable that UVB appears to be a key factor in the pathogenesis of PKDL. Immunopathologically the lesions were characterized by an influx of various inflammatory cells. The number of CD1a (Langerhans' cells) was decreased, they lost their dendrites, their HLA-DR and B7-1 expression was down regulated while B7-2 was expressed. Others have shown that Langerhans' cells with these features result from UVB exposure and that such cells are unable to present antigen to Th1 cells while retaining the capacity to present antigen to Th2 cells. Various cytokines known to be induced by UVB radiation could be demonstrated in PKDL lesions. Of these IL-10, TGF-beta, IL-12, IL-4 and TNF-alpha were found in different quantities. The Th-1 cytokine IFN-gamma was constantly present. The tissue origin of the Th-1 cells in PKDL is unknown. We believe that the antagonistic action of the different cytokines is the cause of the inflammation and chronicity of PKDL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16386855     DOI: 10.1016/j.mehy.2005.03.035

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  14 in total

1.  Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.

Authors:  Dinesh Mondal; Kamrul Nahar Nasrin; M Mamun Huda; Mamun Kabir; Mohammad Shakhawat Hossain; Axel Kroeger; Tania Thomas; Rashidul Haque
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

Review 2.  Post kala-azar dermal leishmaniasis: an unresolved mystery.

Authors:  Debanjan Mukhopadhyay; Jane E Dalton; Paul M Kaye; Mitali Chatterjee
Journal:  Trends Parasitol       Date:  2014-01-02

Review 3.  The immunology of post-kala-azar dermal leishmaniasis (PKDL).

Authors:  Eduard E Zijlstra
Journal:  Parasit Vectors       Date:  2016-08-23       Impact factor: 3.876

Review 4.  Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

Authors:  Eduard E Zijlstra; Fabiana Alves; Suman Rijal; Byron Arana; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2017-11-16

Review 5.  Cutaneous Manifestations of Human and Murine Leishmaniasis.

Authors:  Breanna M Scorza; Edgar M Carvalho; Mary E Wilson
Journal:  Int J Mol Sci       Date:  2017-06-18       Impact factor: 5.923

6.  Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.

Authors:  Brima M Younis; Mohamed Osman; Eltahir A G Khalil; Francesco Santoro; Simone Furini; Rebecca Wiggins; Ada Keding; Monica Carraro; Anas E A Musa; Mujahid A A Abdarahaman; Laura Mandefield; Martin Bland; Toni Aebischer; Rhian Gabe; Alison M Layton; Charles J N Lacey; Paul M Kaye; Ahmed M Musa
Journal:  Mol Ther       Date:  2021-03-27       Impact factor: 11.454

7.  Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients.

Authors:  Eltahir Awad Gasim Khalil; Selma Abdelmoneim Khidir; Ahmed Mudawi Musa; Brema Younis Musa; Mona Elfaki Eltahir Elfaki; Abdelgadir Mohamed Yousif Elkadaru; Edward Zijlstra; Ahmed Mohamed El-Hassan
Journal:  J Trop Med       Date:  2013-03-24

8.  Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan.

Authors:  A M Musa; E A G Khalil; B M Younis; M E E Elfaki; M Y Elamin; A O A Adam; H A A Mohamed; M M M Dafalla; A A Abuzaid; A M El-Hassan
Journal:  J Trop Med       Date:  2013-04-15

9.  Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis.

Authors:  Ahmed Mohamed El Hassan; Eltahir Awad Gasim Khalil; Waleed Mohamed Elamin; Lamyaa Ahmed Mohamed El Hassan; Mogtaba Elsaman Ahmed; Ahmed Mudawi Musa
Journal:  Case Rep Med       Date:  2013-02-21

Review 10.  A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

Authors:  Waleed Al-Salem; Jennifer R Herricks; Peter J Hotez
Journal:  Parasit Vectors       Date:  2016-08-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.